🚨 EXCLUSIVE: Hims board member David Wells on why he bought $1.2M of Hims

Jul 1, 2026 · 0:51:24

Listen to Episode

✨ AI Summary

Board member David Wells explains his $1.2M Hims share purchase.
He believes Hims is at an inflection point post-Novo dispute.
Wells sees Hims as a healthcare platform addressing systemic issues.

Guests on This Episode

American librarian · 1 podcast appearance

More from Hims House

Enhanced Group CEO: Hot peptide summer is coming — but likely not till 2027

Aug 7, 2026 · 0:54:27

🚨 FDA committee votes "YES" on 6 of 7 peptides — here's what happens next, with Dr. Alex Tatem

Jul 27, 2026 · 0:59:34

The FDA peptides vote is days away. This insider expects approval

Jul 15, 2026 · 1:01:14

Ryan MacDonald: Peptides could be a $30B+ market, and Hims is positioned to win meaningful share

Jul 7, 2026 · 1:00:30

View all episodes →